Binex shares boosted by Samsung Electronics acquisition

Published: 2009-08-18 06:58:00

Updated: 2009-08-18 06:58:00

Shares of Binex Co., a Korean pharmaceutical firm, were boosted on August 13 by expectations that Samsung Electronics Co., the world's second-largest maker of chips and mobile phones, will acquire Binex as part of efforts to enter the global bio-similar market.

Binex shares hit a record high o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK